Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01241149
Other study ID # CIP# 10.0090
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2010
Est. completion date March 26, 2014

Study information

Verified date May 2024
Source United States Naval Medical Center, Portsmouth
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Gastroesophageal reflux disease (GERD) is a common ailment affecting a significant portion of the US population. With the advent and increased use of esophageal impedance monitoring, both acid and nonacid reflux disease can be better diagnosed and treated. Patients with severe symptoms or symptoms refractory to medical management may be offered anti-reflux surgery for optimal treatment. Though there are a handful of studies evaluating the efficacy of anti-reflux surgery on those patients with acid or non-acid related reflux disease, the comparison between acid and non-acid reflux disease following surgery is lacking. We propose a prospective study comparing clinical outcomes from those patients with acid versus non-acid reflux disease following anti-reflux surgery with the use of validated and disease specific quality of life surveys.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date March 26, 2014
Est. primary completion date March 26, 2014
Accepts healthy volunteers No
Gender All
Age group 17 Years and older
Eligibility Inclusion Criteria: - Patients who are offered anti-reflux surgical treatment with elevated DeMeester scores or with low (less than 14.7) DeMeester scores, but with positive impedance scores (positive symptom index associated with reflux episodes). Exclusion Criteria: - • Previous major upper gastrointestinal surgery (includes esophagus, stomach, and duodenum) - previous cholecystectomy (gallbladder removal) is not considered a major upper GI surgery - Presence of paraesophageal hernia (type II - type IV) - Presence of large hiatal hernia >5cm - Presence of peptic strictures - History of severe esophageal motility disorders such as: - achalasia - diffuse esophageal spasms - scleroderma - poorly-controlled diabetes mellitus - autonomic or peripheral neuropathy - myopathy - Pregnancy (As a standard operating procedure, women of child-bearing age will undergo a urine pregnancy test the morning of surgery because anti-reflux surgery is considered an elective case, where pregnancy is a relative contraindication.) - BMI greater than 40 - Undergoes Collis gastroplasty during surgery - Conversion to an open procedure - Age less than 18 years old

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
anti-reflux surgery
Anti-reflux surgery (Laparoscopic Nissen Fundoplication)

Locations

Country Name City State
United States Naval Medical Center Portsmouth Portsmouth Virginia

Sponsors (1)

Lead Sponsor Collaborator
United States Naval Medical Center, Portsmouth

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effectiveness of anti-reflux surgery To prospectively evaluate the effectiveness of anti-reflux surgery, as measured by symptom reduction, in the treatment of nonacid reflux disease compared prospectively with acid reflux disease. 1 year